Peritonitis: Update on pathophysiology, clinical manifestations, and management

被引:71
作者
Johnson, CC
Baldessarre, J
Levison, ME
机构
[1] ALLEGHENY UNIV HLTH SCI, MCP, DIV INFECT DIS, PHILADELPHIA, PA 19129 USA
[2] RW JOHNSON PHARMACEUT RES INST, RARITAN, NJ 08869 USA
[3] VET AFFAIRS MED CTR, PHILADELPHIA, PA USA
关键词
D O I
10.1086/513658
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1035 / 1045
页数:11
相关论文
共 98 条
[31]   ENVIRONMENTAL MYCOBACTERIAL PERITONITIS COMPLICATING PERITONEAL-DIALYSIS - 3 CASES AND REVIEW [J].
HAKIM, A ;
HISAM, N ;
REUMAN, PD .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (03) :426-431
[32]   ENDOTOXIN, TNF-ALPHA, INTERLEUKIN-6 AND PARAMETERS OF THE CELLULAR IMMUNE-SYSTEM IN PATIENTS WITH INTRAABDOMINAL SEPSIS [J].
HAMILTON, G ;
HOFBAUER, S ;
HAMILTON, B .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (03) :361-368
[33]  
HOLMES CJ, 1986, PERITON DIALYSIS INT, V6, P168
[34]  
HOLMES CJ, 1994, KIDNEY INT S48, V46, pS58
[35]  
HOLZHEIMER RG, 1995, ARCH SURG-CHICAGO, V130, P1314
[37]  
KACZMARSKI EB, 1988, AM J KIDNEY DIS, V14, P413
[38]  
KEANE WF, 1987, PERITON DIALYSIS B, V7, P55
[39]   DRUG-THERAPY IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].
KELLER, E ;
REETZE, P ;
SCHOLLMEYER, P .
CLINICAL PHARMACOKINETICS, 1990, 18 (02) :104-117
[40]  
KOHLER J, 1993, J IMMUNOL, V151, P916